Showing results (1661-1670 of 1,799) with videos related to

Sort By:
Pageof 180
Mabs|March 10, 2015
Potent neutralizing anti-CD1d antibody reduces lung cytokine release in primate asthma modelJonathan Nambiar, Adam W Clarke, Doris Shim, et al.
Mabs|May 15, 2023
10th antibody industrial symposium: new developments in antibody and adoptive cell therapiesAna Antunes, Luis Alvarez-Vallina, Federico Bertoglio, et al.
Mabs|May 16, 2023
High concentration formulation developability approaches and considerationsJonathan Zarzar, Tarik Khan, Maniraj Bhagawati, et al.
Mabs|May 30, 2014
Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenograftsSonia Chamorro, Maria Vela, Ana Franco-Villanueva, et al.
Mabs|August 4, 2020
A general evidence-based sequence variant control limit for recombinant therapeutic protein developmentAming Zhang, Zhengwei Chen, Meinuo Li, et al.
Mabs|August 4, 2020
Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignanciesMitchell Evers, Toine Ten Broeke, J H Marco Jansen, et al.
Mabs|August 4, 2020
Conjugation of a peptide to an antibody engineered with free cysteines dramatically improves half-life and activityRaul C Camacho, Seohee You, Katharine E D'Aquino, et al.
Mabs|March 20, 2015
An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodiesPatricia Estep, Isabelle Caffry, Yao Yu, et al.
Mabs|July 10, 2020
A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu14.18K322A in recurrent/refractory solid tumorsMichael W Bishop, Paul R Hutson, Jacquelyn A Hank, et al.
Mabs|May 17, 2014
Generation of a high-fidelity antibody against nerve growth factor using library scanning mutagenesis and validation with structures of the initial and optimized Fab-antigen complexesSherry L La Porte, Charles Eigenbrot, Mark Ultsch, et al.
Pageof 180